During the past decade, Merced Heart Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Merced Heart Associates" #1 sponsor was "Forest Laboratories" with 2 trials, followed by "Abbott" with 1 trials sponsored, "AtheroGenics" with 1 trials sponsored, "CTI-1, LLC" with 1 trials sponsored and "CardioKine Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Merced Heart Associates" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Merced Heart Associates" are "Coronary Artery Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Congestive Heart Failure" (2 trials), "Heart Failure, Congestive" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Merced Heart Associates" in a lesser frequency.

Most popular intervention types in "Merced Heart Associates" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Azimilide Dihydrochloride" (2 trials), "AGI-1067" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Levosimendan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Merced Heart Associates" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Merced Heart Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Merced Heart Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Merced Heart Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".